SCHEMBL6166884

SCHEMBL6166884

O=C1Nc2ccccc2C(c2cccc(Cl)c2)N1C1CCN(Cc2ccccc2)CC1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRM3 P20309 7/20 0.51
CHRM2 P08172 6/20 0.51
DRD2 P14416 2/20 0.48
DRD4 P21917 2/20 0.48
DRD3 P35462 1/20 0.48
OPRM1 P35372 1/20 0.48
KDM4E B2RXH2 1/20 0.46
ALDH1A1 P00352 1/20 0.46
GLA P06280 1/20 0.46
GAA P10253 1/20 0.46
MAPT P10636 1/20 0.46
HTT P42858 1/20 0.46
ATM Q13315 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
OPRL1 P41146 1/20 0.46
SIGMAR1 Q99720 2/20 0.45
CYP2D6 P10635 1/20 0.44
CYP2C9 P11712 1/20 0.44
CYP2C19 P33261 1/20 0.44
CHRM1 P11229 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8564439 0.95 CHRM2 (0.55) CHRM3CHRM2DRD2DRD4DRD3
SCHEMBL6168606 0.90 OPRL1 (0.52) CHRM3CHRM2DRD2DRD4DRD3
SCHEMBL29445321 0.90 OPRL1 (0.52) CHRM3CHRM2DRD2DRD4DRD3
SCHEMBL6167614 0.90 CHRM2 (0.44) CHRM3CHRM2DRD2DRD4DRD3
SCHEMBL6168575 0.89 CHRM3 (0.50) CHRM3CHRM2DRD2DRD4DRD3
SCHEMBL6168075 0.89 CHRM3 (0.50) CHRM3CHRM2ALDH1A1OPRL1SIGMAR1
Hydrochloric Acid SCHEMBL6166573 0.88 CHRM3 (0.49) CHRM3CHRM2DRD2DRD4DRD3
SCHEMBL6168165 0.88 CHRM3 (0.49) CHRM3CHRM2DRD2DRD4DRD3
SCHEMBL8569508 0.88 MEN1 (0.53) CHRM3CHRM2DRD2DRD4DRD3
SCHEMBL8567873 0.87 MEN1 (0.49) CHRM3CHRM2DRD2DRD4DRD3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1122253-B1 QUINAZOLINONE DERIVATIVES SUMITOMO PHARMA (JP) 2005-08-17 EP disclosed
US-6645971-B1 Pollakiuria and urinary incontinence treatment; muscarinic receptor antagonists; anticholinergic, anticonvulsants, antiulcer, and antiasthmatics; Parkinson*s disease SUMITOMO PHARMACEUTICALS COMPANY LIMITED (JP) 2003-11-11 US disclosed
EP-1122253-A1 QUINAZOLINONE DERIVATIVES SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) 2001-08-08 EP disclosed